Skip to main navigation
Skip to search
Skip to main content
Maastricht University Home
Support & FAQ
Home
Researchers
Publications
Activities
Press/Media
Prizes
Organisations
Dataset/Software
Projects
Search by expertise, name or affiliation
Use of Radionuclide-Based Imaging Methods in Breast Cancer
Betül Altunay
, Agnieszka Morgenroth
,
Felix M Mottaghy
*
*
Corresponding author for this work
Beeldvorming
GROW - Innovative Cancer Diagnostics & Therapy
NUTRIM - Metabolic Health
Carim - Imaging
MHeNs - Cognitive Neuropsychiatry and Clinical Neuroscience
Research output
:
Contribution to journal
›
(Systematic) Review article
›
peer-review
Overview
Fingerprint
Fingerprint
Dive into the research topics of 'Use of Radionuclide-Based Imaging Methods in Breast Cancer'. Together they form a unique fingerprint.
Sort by
Weight
Alphabetically
Keyphrases
Breast Cancer
100%
Imaging Methods
100%
Conventional Imaging
100%
Radionuclides
100%
Non-invasive Method
100%
Immunohistochemistry
50%
Survival Rate
50%
Repeated Measurements
50%
Patient Selection
50%
Diagnostic Techniques
50%
Molecular Imaging
50%
Disease Progression
50%
Response Assessment
50%
Hormone Receptor-positive
50%
Fluorescence in Situ Hybridization
50%
Cancer Mortality
50%
Hormone Receptor
50%
Breast Cancer Diagnosis
50%
Cancer Causes
50%
Heterogeneous Tumors
50%
Tumor Expression
50%
Receptor Status
50%
Medicine and Dentistry
Breast Cancer
100%
Radioisotope
100%
Hormone Receptor
66%
Conventional Imaging
66%
Non Invasive Procedure
66%
Immunohistochemistry
33%
Neoplasm
33%
Cancer
33%
Receptor
33%
Patient Selection
33%
Cancer Mortality
33%
Molecular Imaging
33%
Cancer Diagnosis
33%
Survival Rate
33%
Disease Exacerbation
33%
Fluorescence in Situ Hybridization
33%
Biopsy Technique
33%
INIS
cancer
100%
breasts
100%
radionuclides
100%
receptors
60%
hormones
40%
diseases
20%
doses
20%
patients
20%
women
20%
tumors
20%
biopsy
20%
fluorescence
20%
females
20%
mortality
20%
assessments
20%
diagnostic techniques
20%
capture
20%
transformations
20%
schedules
20%
in-situ hybridization
20%
Biochemistry, Genetics and Molecular Biology
Hormone Receptor
100%
Survival Rate
50%
Fluorescence in Situ Hybridization
50%
Cancer Mortality
50%